Uh huh.... right... since it's marketed in over hundreds of trials (ELITE, ELITE II, CHARM, SOLVD, CONCENSUS trials) with tens of thousands of cardiac patients demonstrating proven benefit as a cardioprotective medication.
NEJM -- ACE Inhibitors in Cardiovascular Disease -- Unbeatable?